Politico Europe reports:
The BioNTech/Pfizer coronavirus vaccine should grant protection against both the South African and British variants, according to an article published in Nature Medicine Monday. The researchers tested the blood sera of participants who had been given the vaccine against virus samples that were genetically modified to resemble the variants, finding that the antibodies responded to these viruses.
The abstract is here.
Coronavirus LIVE as small study finds Pfizer/BioNTech Covid vaccine ‘effective against South Africa variant’https://t.co/FsD2VcQtlX
— Manchester News MEN (@MENnewsdesk) February 8, 2021